EP3417294
METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB
:
EP einkaleyfi: Þýðing ekki lögð inn:
14.2.2017:
1.12.2021:
17753704.0
:
13.2.2037
:
METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB
14.2.2017
1.12.2021
:
Astrazeneca AB:
151 85 Södertälje, SE
:
The United States of America, as Represented By the Secretary, Department of Health and Human Services:
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20892-7660, US
:
BARRY, Simon:
Cambridge CB4 0WG, GB
:
KENDREW, Jane:
Macclesfield Cheshire SK10 4TG, GB
:
HO, Tony:
Gaithersburg, MD 20878, US
:
WEDGE, Stephen, Robert:
Granta Park Cambridge CB21 6GH, GB
:
IVY,Susan Percy:
Bethesda, MD 20892-7660, US
:
KOHN, Elise:
Bethesda, MD 20892-7660, US
:
LEE, Jung-Min:
Bethesda, MD 20892-7660, US
:
201662295421 P:
15.2.2016:
US
:
US2017017804:
14.2.2017
:
C07K 16/28, G01N 33/574, A61K 38/00, A61P 35/00, A61K 31/502, A61K 31/506, A61K 45/06, A61K 48/00, A61P 9/10, A61P 43/00, A61K 39/395